70 A Randomized, Double-Blind, Placebo-Controlled Phase II Study (MOT114479) to Evaluate the Safety and Efficacy and Dose Response of 28 Days of Orally Administered Camicinal, a Motilin Receptor Agonist, in Diabetics With GastroparesisMatthew E. Barton, George E. Dukes, Henry P. Parkman et al.|Gastroenterology|2014Cited by 34
Distinct neurophysiological profiles in irritable bowel syndromeNaila Arebi, Anthony Hobson, Dominic Bullas et al.|American Journal of Physiology-Gastrointestinal and Liver Physiology|2011Cited by 14
Neurophysiological evaluation of convergent afferents innervating the human esophagus and area of referred pain on the anterior chest wallAnthony Hobson, George E. Dukes, Boris A. Chizh et al.|American Journal of Physiology-Gastrointestinal and Liver Physiology|2009Cited by 13
Tu1472 Multimodal Assessment of Gastric Residence Time, Whole Bowel Transit, Esophageal Function and Gastro-Esophageal Reflux Following Administration of the Motilin Agonist (GSK962040) in Healthy SubjectsAnthony Hobson, George E. Dukes, Odile Dewit et al.|Gastroenterology|2012Cited by 1
PTH-034 Stress-induced immunomodulation in irritable bowel syndrome suppresses Th1 and Th2 cytokinesDominic Bullas, Anthony Hobson, Kirsty Hicks et al.|Unknown|2010Cited by 0